NO985979L - 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse - Google Patents

1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse

Info

Publication number
NO985979L
NO985979L NO985979A NO985979A NO985979L NO 985979 L NO985979 L NO 985979L NO 985979 A NO985979 A NO 985979A NO 985979 A NO985979 A NO 985979A NO 985979 L NO985979 L NO 985979L
Authority
NO
Norway
Prior art keywords
preparation
benzothiadiazine derivatives
compounds
benzothiadiazine
derivatives
Prior art date
Application number
NO985979A
Other languages
English (en)
Norwegian (no)
Other versions
NO985979D0 (no
Inventor
Bernard Pirotte
Philippe Lebrun
Pascal De Tullio
Fabian Somers
Jacques Delarge
John Bondo Hansen
Flemming Elmelund Nielsen
Holger Claus Hansen
John Patrick Mogensen
Tina M Ller Tagmose
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO985979D0 publication Critical patent/NO985979D0/no
Publication of NO985979L publication Critical patent/NO985979L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO985979A 1996-06-21 1998-12-18 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse NO985979L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK69396 1996-06-21
DK145196 1996-12-19
PCT/DK1997/000266 WO1997049692A1 (en) 1996-06-21 1997-06-19 1,2,4-benzothiadiazine derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
NO985979D0 NO985979D0 (no) 1998-12-18
NO985979L true NO985979L (no) 1999-02-19

Family

ID=26064470

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985979A NO985979L (no) 1996-06-21 1998-12-18 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse

Country Status (18)

Country Link
US (1) US6242443B1 (de)
EP (1) EP0906297B1 (de)
JP (1) JP2000512641A (de)
KR (1) KR20000022087A (de)
CN (1) CN1081633C (de)
AT (1) ATE260266T1 (de)
AU (1) AU737920B2 (de)
BR (1) BR9709858A (de)
CA (1) CA2258100A1 (de)
CZ (1) CZ413198A3 (de)
DE (1) DE69727806T2 (de)
ES (1) ES2216155T3 (de)
HU (1) HUP9904032A3 (de)
IL (1) IL127368A0 (de)
MX (1) MXPA98010773A (de)
NO (1) NO985979L (de)
PL (1) PL330815A1 (de)
WO (1) WO1997049692A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2288154A1 (en) * 1997-04-28 1998-11-05 Michael J. Kelley Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer
AU1555999A (en) * 1997-12-19 1999-07-12 Novo Nordisk A/S 1,2,4-benzothiadiazine derivatives, their preparation and use
US6943159B1 (en) 1998-02-18 2005-09-13 Neurosearch A/S Compounds and their use as positive AMPA receptor modulators
AU2001265840A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel agonists for reducing fat food comsumption
WO2002064578A1 (en) * 2001-02-14 2002-08-22 Warner-Lambert Company Llc Benzo thiadiazine matrix metalloproteinase inhibitors
JP2007504136A (ja) 2003-08-28 2007-03-01 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法
WO2006091716A2 (en) 2005-02-24 2006-08-31 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
CN102584649A (zh) * 2006-06-22 2012-07-18 安那迪斯药品股份有限公司 吡咯并[1,2-b]哒嗪酮化合物
US20090257979A1 (en) * 2008-04-15 2009-10-15 Intermune, Inc. Novel Inhibitors of Hepatitis C Virus Replication
US20120053172A1 (en) 2009-02-12 2012-03-01 Cooperatieve Mirzorg U.A. Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders
WO2010111518A1 (en) * 2009-03-27 2010-09-30 Yale University Treatment and prevention of white matter injury with katp channel activators
TW201121968A (en) * 2009-11-09 2011-07-01 Intermune Inc Novel inhibitors of hepatitis C virus replication
WO2015117024A1 (en) 2014-01-31 2015-08-06 Mayo Foundation For Medical Education And Research Novel therapeutics for the treatment of glaucoma
WO2017098421A1 (en) * 2015-12-08 2017-06-15 Glaxosmithkline Intellectual Property Development Limited Benzothiadiazine compounds
EP4592279A3 (de) 2018-05-11 2025-09-03 University of Florida Research Foundation, Incorporated Myelinisierungsstimulatorverbindungen und behandlungsverfahren
NL2022291B1 (en) * 2018-12-21 2020-07-21 Academisch Ziekenhuis Leiden Compound for Use in Treatment and Prevention of Type I Diabetes
EP3962901A1 (de) 2019-04-29 2022-03-09 Solent Therapeutics, LLC 3-amino-4h-benzo[e][1,2,4]thiadiazin-1,1-dioxidderivate als inhibitoren von mrgx2
AU2020403144A1 (en) 2019-12-12 2022-07-14 Mayo Foundation For Medical Education And Research Controlled-delivery cromakalim prodrugs
CN110903264B (zh) * 2019-12-26 2021-06-18 苏州大学 一种制备二氮嗪的方法
WO2021236818A1 (en) * 2020-05-19 2021-11-25 Board Of Regents Of The University Of Nebraska Halogenated benzothiadiazines for the treatment of cancer
AU2023365206A1 (en) * 2022-10-18 2025-04-24 Rhythm Pharmaceuticals, Inc. Novel atp-sensitive potassium channel potentiators, their preparation and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3269906A (en) 1966-08-30 Imino-j,x-dihydro-l,z,x-benzothiadiazine- i,i-dioxides
GB847176A (en) * 1958-06-20 1960-09-07 Lepetit Spa Benzothiadiazine compounds
DE2548283A1 (de) * 1974-10-29 1976-05-06 Dainippon Pharmaceutical Co 1,2,4-benzothiadiazin-1,1-dioxidderivate
SE402773B (sv) 1976-04-20 1978-07-17 Dainippon Pharmaceutical Co Forfarande for framstellning av 1,2,4-bensotiadiazin-1,1-dioxid-derivat
DE2757922A1 (de) * 1977-12-24 1979-06-28 Bayer Ag Substituierte alkylenamino-1.2.4- benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2757925A1 (de) * 1977-12-24 1979-06-28 Bayer Ag Diazacyclo-1.2.4-benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
JP2000512641A (ja) 2000-09-26
BR9709858A (pt) 1999-08-10
IL127368A0 (en) 1999-10-28
CN1222910A (zh) 1999-07-14
US6242443B1 (en) 2001-06-05
PL330815A1 (en) 1999-06-07
DE69727806T2 (de) 2005-01-13
CZ413198A3 (cs) 1999-06-16
AU3166497A (en) 1998-01-14
HUP9904032A2 (hu) 2000-03-28
EP0906297A1 (de) 1999-04-07
MXPA98010773A (es) 2002-06-11
ATE260266T1 (de) 2004-03-15
CA2258100A1 (en) 1997-12-31
EP0906297B1 (de) 2004-02-25
CN1081633C (zh) 2002-03-27
DE69727806D1 (de) 2004-04-01
AU737920B2 (en) 2001-09-06
HUP9904032A3 (en) 2001-11-28
KR20000022087A (ko) 2000-04-25
ES2216155T3 (es) 2004-10-16
NO985979D0 (no) 1998-12-18
WO1997049692A1 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
NO985979D0 (no) 1,2,4-benzotiadiazinderivater, deres fremstilling og anvendelse
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
NO991732L (no) Nye heterocyklylmetylsubstituerte pyrazolderivater
PL365026A1 (en) Pyrazole derivatives for treating hiv
CA2269815A1 (en) Thienopyrimidines having pde v-inhibiting action
IL162498A0 (en) (N-sulphonamido) acetamide derivatives and pharmaceutical compositions containing the same
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
WO2001066564A3 (en) Gamma-secretase inhibitors
MY133392A (en) Novel substituted pyrazole derivatives
DK1140945T3 (da) Kondenserede 1,2,4-thiadiazinderivater, deres fremstilling og anvendelse
CA2260213A1 (en) Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
CA2134964A1 (en) Bridged Aza-Bicyclic Derivatives as Substance P Antagonists
NO20030301L (no) Nye heteroarylderivater og anvendelse derav som farmasöytika
CA2226256A1 (en) New thrombin inhibitors, their preparation and use
NO994671L (no) Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmåte til fremstilling derav og deres anvendelse som farmasöytika
NO995431L (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
CA2114727A1 (en) Quinoline Derivatives as Immunostimulants
HK1046404A1 (zh) 用作nmda受体拮抗剂的取代的吡咯烷-2，3，4-三酮-3-肟衍生物
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
CA2168193A1 (en) Aryalkyl-thiadiazinones
WO2001005386A3 (en) Pharmaceutical composition useful for the treatment of tinnitus and hearing loss
NO983285D0 (no) Pyrido-1,2,4-tiadiazin- og pyrido-1,4-tiazinderivater, deres fremstilling og anvendelse
CA2011642A1 (en) Benzoxazine dyes
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet
ES8604853A1 (es) Un metodo para la preparacion de un derivado de acetileno.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application